- Chief Compliance Officer and VP of Legal Affairs, Arrow Electronics
By 
Aaron Nicodemus2024-01-25T18:01:00
Third parties in China are at high risk of participating in bribery schemes with government employees. U.S. regulators have prosecuted violations of the Foreign Corrupt Practices Act (FCPA) in China more than any other country by a significant margin.
There have been 117 FCPA cases since 1978 involving violations in China prosecuted by the Department of Justice (DOJ) and Securities and Exchange Commission (SEC), according to statistics compiled by law firm Gibson Dunn. Nigeria (77) was a distant second, followed closely by Mexico (67), Brazil (60), Indonesia (53), and Iraq (51).
This is not to say corruption in China is worse than the other countries, said Kelly Austin, a Gibson Dunn partner, in a recent webcast held by the firm on FCPA enforcement trends in emerging markets.
THIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.
News and analysis for the well-informed compliance or audit exec. Select an option and click continue.
Annual Membership $499 Value offer
Full price one year membership with auto-renewal.
Membership $599
One-year only, no auto-renewal.
Recent enforcement actions offer guidance on what the Department of Justice considers to be an “imminent threat” of disclosure or government action, what it means by “prompt” disclosure, and how a company can earn credit for revealing all relevant facts.
Multinational produce and agriculture company Calavo Growers disclosed in an annual filing an investigation into its Mexico operations found potential issues under the Foreign Corrupt Practices Act.
GE HealthCare said it is cooperating with reviews by the Department of Justice and Securities and Exchange Commission into potential violations of the Foreign Corrupt Practices Act in China.
USAA Federal Savings Bank has been hit with its third cease and desist order from the Treasury Department’s Office of the Comptroller of the Currency in the past five years for failing to correct unsafe and unsound banking practices.
Becton Dickinson medical device company will pay $175 million for “repeatedly” misleading investors about its Alaris infusion pump, a product the company knew was flawed and was sold without the required patient-safety approvals, the Securities and Exchange Commission said.
The Securities and Exchange Commission charged bankrupt fashion retailer Express with failing to disclose nearly $1 million in perks to a former chief executive, but did not levy a financial penalty thanks to its cooperation, the SEC said.
